Reducing the impact of rheumatic diseases in childhood

J D Akikusa1, R C Allen

  • 1Rheumatology and General Practice, Royal Children's Hospital, Flemington Rd, Parkville, Melbourne 3052, Australia.

Insights

This chapter focuses on non-pharmacological therapies for juvenile idiopathic arthritis (JIA) in children. It explores physical rehabilitation, schooling, and psychosocial support to minimize the disease

Area of Science:

  • Pediatric Rheumatology
  • Child Health Management
  • Non-pharmacological Interventions

Background:

  • Rheumatic diseases significantly impact children's physical development and psychosocial well-being.
  • A multidisciplinary team approach is crucial for managing childhood rheumatic diseases.
  • Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children.

Purpose of the Study:

  • To examine non-pharmacological management strategies for juvenile idiopathic arthritis (JIA).
  • To address the physical, psychosocial, and educational challenges faced by children with JIA.
  • To provide evidence-based principles for reducing the impact of childhood rheumatic diseases.

Main Methods:

  • Review of non-pharmacological therapies and interventions for JIA.
  • Discussion of physical rehabilitation, schooling, and medication compliance.
  • Examination of pain management strategies and family dynamics.
  • Application of evidence-based principles from scientific literature.

Main Results:

  • Non-pharmacological approaches are vital for addressing the multifaceted effects of JIA.
  • Interventions targeting physical development, education, and psychosocial well-being are essential.
  • Evidence-based strategies can effectively minimize the disease's impact and sequelae.

Conclusions:

  • Comprehensive, non-pharmacological management is key to improving outcomes for children with JIA.
  • The principles discussed are applicable to a broader range of childhood rheumatic diseases.
  • Addressing physical, educational, and psychosocial aspects is fundamental to holistic care.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...